Daniel Schneiderman
Director of Finance/CFO bei PASITHEA THERAPEUTICS CORP.
Vermögen: - $ am 31.03.2024
Profil
Daniel H.
Schneiderman is currently the Chief Financial Officer at Pasithea Therapeutics Corp.
He previously held positions as Director at Unleashed Ny from 1996 to 2000, Vice President-Investment Banking at Burnham Hill Partners LLC from 2004 to 2012, Secretary, Vice President-Finance & Controller at MetaStat, Inc. from 2012 to 2018, Chief Financial Officer at Biophytis SA in 2018-2019, and Chief Financial Officer at First Wave Biopharma, Inc. from 2020 to 2022.
He also served as Chief Financial Officer at Biophytis, Inc. Mr. Schneiderman received an undergraduate degree from Tulane University (Louisiana).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 23.03.2024 | 0 ( -.--% ) | - $ | 31.03.2024 |
Aktive Positionen von Daniel Schneiderman
| Unternehmen | Position | Beginn |
|---|---|---|
| PASITHEA THERAPEUTICS CORP. | Director of Finance/CFO | 11.10.2022 |
Ehemalige bekannte Positionen von Daniel Schneiderman
| Unternehmen | Position | Ende |
|---|---|---|
| FIRST WAVE BIOPHARMA, INC. | Director of Finance/CFO | 28.02.2022 |
| BIOPHYTIS S.A. | Director of Finance/CFO | 01.12.2019 |
| METASTAT, INC. | Comptroller/Controller/Auditor | 01.08.2018 |
Burnham Hill Partners LLC
 Burnham Hill Partners LLC Investment Banks/BrokersFinance Burnham Hill Partners LLC engages in security brokers, dealers, and flotation companies. The company was founded by Jason T. Adelman on July 31, 2003 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.2012 |
| Unleashed Ny | Director/Board Member | 01.01.2000 |
Ausbildung von Daniel Schneiderman
| Tulane University (Louisiana) | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| BIOPHYTIS S.A. | Health Technology |
| METASTAT, INC. | Producer Manufacturing |
| FIRST WAVE BIOPHARMA, INC. | Health Technology |
| PASITHEA THERAPEUTICS CORP. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Burnham Hill Partners LLC
Burnham Hill Partners LLC Investment Banks/BrokersFinance Burnham Hill Partners LLC engages in security brokers, dealers, and flotation companies. The company was founded by Jason T. Adelman on July 31, 2003 and is headquartered in New York, NY. | Finance |
| Unleashed Ny | |
Biophytis, Inc.
 Biophytis, Inc. Pharmaceuticals: MajorHealth Technology Part of Biophytis SA, Biophytis, Inc. operates as a clinical-stage biotechnology company which develops therapeutics for aging and improving functional outcomes. The private company is based in Newark, DE. | Health Technology |
